Janet Bradley
Psychiatry · New Orleans, LANPI 1487774527
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.5% of the total across 295 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 27.5% of the total. Among psychiatry clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 295 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$803
- Otsuka America Pharmaceutical, Inc.$678
- Johnson & Johnson$673
- Lundbeck LLC$639
- plus $365 from 4 others
What the payments were for
- Food & beverage$5,73594%
- Education$3986%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 61 | $1,688 |
| Teva Pharmaceuticals USA, Inc. | 76 | $1,288 |
| Alkermes, Inc. | 39 | $803 |
| Otsuka America Pharmaceutical, Inc. | 28 | $678 |
| Johnson & Johnson | 28 | $673 |
| Lundbeck LLC | 37 | $639 |
| E.r. Squibb & Sons, L.L.C. | 12 | $176 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $154 |
| Indivior Inc. | 1 | $19 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$597
- ABILIFY MAINTENA$122
How this compares
$6,133 in reported general payments places this provider in the 90th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 195 | $643,595 |
| Abilify MaintenaAripiprazole | 70 | $208,358 |
| Invega TrinzaPaliperidone Palmitate | 23 | $193,126 |
| IngrezzaValbenazine Tosylate | 15 | $112,276 |
| AristadaAripiprazole Lauroxil | 14 | $45,577 |
| TrulicityDulaglutide | 13 | $12,397 |
| Metformin Hcl | 32 | $8,036 |
| Chlorpromazine Hcl | 36 | $4,970 |
| Haloperidol Decanoate | 152 | $4,852 |
| Divalproex Sodium ErDivalproex Sodium | 148 | $4,790 |
| Quetiapine Fumarate | 227 | $2,060 |
| Mirtazapine | 120 | $1,964 |
| Trazodone Hcl | 145 | $1,877 |
| Benztropine Mesylate | 162 | $1,848 |
| Haloperidol | 71 | $1,838 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $673 | $836,721218 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $678 | $208,35870 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,688 | $112,27615 claims |
| Alkermes, Inc.Aristada | $803 | $45,57714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 474 psychiatry providers in Louisiana.
Other psychiatry in New Orleans
- Arwen PodestaNew Orleans$466K
- Andrew MorsonNew Orleans$56K
- James BarbeeNew Orleans$28K
- Neha KansaraNew Orleans$13K
- Erich ConradNew Orleans$9K
- Rahn BaileyNew Orleans$8K
- Nick RamandiNew Orleans$8K
- Ashley WeissNew Orleans$8K
- Ravindra ReddyNew Orleans$7K
- Paul PeltsNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.